WT1 and familial pancreatic carcinoma: The patient was administered a three-drug combination of antigen-pulsed DCs loaded with WT1 peptides (highly expressed in pancreatic cancer), S-1, and OK-432 (an adjuvant for the WT1-DC vaccine).